ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

A Weighted Approach to Composite Efficacy Analysis in Kidney Transplantation.

B. Kaplan, K. MaCague, D. Patel, F. Vincenti.

Mayo Clinic, Phoenix
Novartis Pharmaceuticals Corporation, East Hanover
University of California, San Francisco.

Meeting: 2016 American Transplant Congress

Abstract number: B122

Keywords: Graft acceptance, Kidney transplantation

Session Information

Date: Sunday, June 12, 2016

Session Name: Poster Session B: Drug Minimization

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Halls C&D

Related Abstracts
  • Exposure Analysis for the Composite Efficacy Endpoints in the US92 Phase 3 Kidney Transplantation Trial to Understand Center Effects.
  • Treatment With Everolimus and Reduced-Exposure Cyclosporine Is Efficacious in De Novo Renal Transplant Recipients at Increased Risk for Efficacy Failure: Post-Hoc Analysis from the A2309 Study

The US92 study determined whether, in de novo renal transplant patients, concentration-controlled everolimus (EVR) with reduced dose tacrolimus (RTAC) is non-inferior to CellCept® (mycophenolate mofetil [MMF] with standard dose tacrolimus [STAC]) on measures of allograft function and safety. Regulatory agencies use composite endpoints(CE) to evaluate transplant drugs where equal weight isaccorded to each component of the CE regardless of clinical significance. Death and graft loss have equal weight as acute rejection. But these endpoints impact patients differently so we analyzed data based on impact of overall endpoint in kidney transplantation, similar to methods adopted in cardiac studies (Ann Thorac Surg. 2012 Dec; 94(6): 1908–1913).

In this 12-month non-inferiority study, safety and efficacy of concentration-controlled EVR (1.5mg/day) with RTAC was compared to MMF (2g/day) with STAC in 613 de novo renal transplant patients. Primary efficacy variable was composite efficacy failure rate (CEFR; treated biopsy-proven acute rejection [tBPAR, based on local biopsy reading], graft loss, death or loss to follow-up) at 12 months post-transplant. In an alternative approach to CEs currently utilized in transplantation trials, different weightings were applied to differentiate clinically important events of death (1), graft loss (0.5), loss to follow-up (0.5), and tBPAR (0.25). Patients with multiple events were assigned the event with the highest weight.

TheobservedCEFRwas24.6%forEVRand20.4%forMMF,aratioof1.206.The ratio using the weighted CEFR was 1.01 (table). An imbalance in 5 baseline risk factors potentially disadvantaged the EVR arm: HLAmismatches≥3, DRlocimismatches, diabetes, deceased donors and extendedcriteriadonors

Weighting of component endpoints Efficacy failure rate
Death Graft loss tBPAR Loss to follow-up EVR MMF Ratio [adjusted difference]
1 0.5 0.25 0.5 15.4 15.2 1.01 [0.2]
1 0.5 0.25 0.25 15.9 14.5 1.10 [1.4]

The CEFR between the 2treatment groups were almost identical for the weighted approach; when the traditional CE was used, EVR had a higher failure rate than MMF. This is indicative of the clinical impact that weighted endpoints offer and is in accordance with other disciplines.

CITATION INFORMATION: Kaplan B, MaCague K, Patel D, Vincenti F. A Weighted Approach to Composite Efficacy Analysis in Kidney Transplantation. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Kaplan B, MaCague K, Patel D, Vincenti F. A Weighted Approach to Composite Efficacy Analysis in Kidney Transplantation. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/a-weighted-approach-to-composite-efficacy-analysis-in-kidney-transplantation/. Accessed March 8, 2021.

« Back to 2016 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Home
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Search
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Home
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.